🚀 Pharmidex at BioWednesday Stevenage 🚀
February 5, 2025
We are excited to share that our Business Development Manager, Janette Dalay Robertson, and Head of Operations,
Ash Alavijeh, had the pleasure of attending the BioWednesday Stevenage: Key Messages and Sentiments from JPM Week 2025 event today at the
Stevenage Bioscience Catalyst.
It was a fantastic opportunity to connect with industry leaders, potential clients, and partners. Janette and Ash were thrilled to engage in meaningful conversations, exploring new collaborations, and discussing the latest insights from JPM Week 2025.
At Pharmidex, we're committed to expanding our relationships and helping our clients navigate their path to success in drug discovery and development. Together, we’re working towards creating a healthier future.
A big thank you to everyone we had the pleasure of meeting today. We look forward to the continued conversations and collaborations!
#Pharmidex #BioWednesday #JPMWeek2025 #DrugDiscovery #Biotech #Innovation #Pharmaceuticals #Networking #StevenageBioScienceCatalyst
Pharmidex is pleased to announce that Ash Alavijeh , will be attending Bio Integrates 2026 on 14 May 2026 at Victoria House, Bloomsbury, London. Ash looks forward to meeting founders, investors, biotech leaders and scientific partners to discuss drug discovery, translational development and new opportunities across the life sciences sector. He will be delighted to connect with attendees and explore new collaborations and partnerships in the drug development field, feel free to catch him for a chat!
We are delighted to welcome Yvonne Squire to the Pharmidex team as our new Senior Histologist. Yvonne brings over 15 years of experience in non-clinical histology and toxicology, with expertise in necropsy, tissue preparation, histochemical techniques and GLP-compliant laboratory operations. Her experience will further strengthen Pharmidex’s histology and translational research capabilities. Welcome to Pharmidex, Yvonne!
We are delighted to announce and congratulate Ash Alavijeh on his appointment as Chief Operating Officer at Pharmidex . Ash has been an integral part of Pharmidex’s journey, bringing strong leadership, strategic vision and a deep commitment to advancing our capabilities in drug discovery and development. In his new role as COO, he will play a key part in driving operational excellence and supporting the continued growth of the company. This appointment reflects both Ash’s contributions to date and our confidence in his leadership as we continue to expand and evolve. Please join us in congratulating Ash on this well-deserved achievement.
